TIGIT and neoplasm: The disruption of TIGIT and CD73 activities promoted the function of iPSC-NK cells after adoptive transfer into intracranial patient-derived glioblastoma models, enhancing their innate cytolytic function against the tumor and ultimately eradicating the tumor [116].